Qualitative Perfusion Assessment of Myocardial Viability Study in Patients Who Cannot Stop Long-acting Nitrate: Serial Case Reports

Authors

  • Erwin A Soeriadi Universitas Padjadjaran
  • Badai B Tiksnadi Universitas Padjadjaran
  • Junan Imaniar Universitas Padjadjaran
  • Hendra Budiawan Universitas Padjadjaran
  • A Hussein S Kartamihardja Universitas Padjadjaran

DOI:

https://doi.org/10.28932/jmh.v3i2.3438

Abstract

The information of myocardial viability status is important to decide the management of CAD. Myocardial viability study (VS) with short-acting nitrate (SAN)-added is recommended to perform inpatient with CAD before revascularization therapy. This study aims to determine whether there are differences in the perfusion results of myocardial viability studies with Long-acting nitrate (LAN) and those with added SAN. Three patients with CAD were referred to our department for myocardial VS to determine the treatment choice. Long-acting nitrate (LAN) was consumed regularly every day and not allowed to be stopped due to the symptomatic chest pain. Patients underwent two myocardial perfusion VS, the first study with continuing the daily routine LAN only and the second one with SAN-added to the daily routine LAN. VS was analyzed qualitatively. The result of this study, no significant perfusion difference between LAN treatment only and SAN-added studies, it is possible the LAN regular dose alone is sufficient to create a vasodilating effect on the arteries without the need for addition of SAN. Conclusion, patients who take LAN routinely, VS might be performed without the need to take additional vasodilator prior to radiopharmaceutical injection.Keywords: coronary artery disease; myocardial perfusion imaging; revascularization therapy; viability study

Downloads

Download data is not yet available.

Downloads

Published

2021-08-17

How to Cite

1.
Soeriadi EA, Tiksnadi BB, Imaniar J, Budiawan H, Kartamihardja AHS. Qualitative Perfusion Assessment of Myocardial Viability Study in Patients Who Cannot Stop Long-acting Nitrate: Serial Case Reports. J. Med. Health [Internet]. 2021Aug.17 [cited 2024Nov.16];3(2). Available from: http://114.7.153.31/index.php/jmh/article/view/3438

Issue

Vol. 3 No. 2 (2021)

Section

Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain the copyright and grant the journal right of first publication with the work
    simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.